Document is current
Any future updates will be listed below
-
Authors
Wang, Meng
Cotter, Edmund
Wang, Ya-Juan
Fu, Xu
Whittsette, Angela L.
Lynch, Joseph W.
Wiseman, R. Luke
Kelly, Jeffery W.
Keramidas, Angelo
Mu, Ting-Wei https://orcid.org/0000-0002-6419-9296
-
Funding
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS105789, R01NS117176)
National Institute on Aging (R01AG046495)
National Health and Medical Research Council (1156673)
- License Information
-
More Information
Article History
Received: 11 January 2022
Accepted: 5 April 2022
First Online: 27 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: RLW and JWK are inventors on patents describing ATF6 activator compounds, including AA147 and AA263. RLW and JWK are also shareholders and scientific advisory board members of Protego Biopharma who have licensed the ATF6 activators AA147 and AA263.
